Phase
Condition
Diabetes (Pediatric)
Diabetes Prevention
Diabetes And Hypertension
Treatment
Type 2 Diabetes Guidebook
VA|PREVENTION web application (digital intervention)
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years old;
FINDRISC Score ≥12 (moderate, high or very high) and/or prediabetes, defined aseither:
HbA1c between 5.7%-6.4% within the last two years; or
Impaired Glucose Tolerance (IGT) based on an Oral Glucose Tolerance Test (OGTT)at the 120-minute mark, with values between 140 and 199 mg/dL in the past threeyears;
Able to understand, speak and write Portuguese;
Able to provide written informed consent;
Access to a smartphone, tablet or computer with internet connection;
Plan to reside in the recruitment/study area for the next 10 months
Exclusion
Exclusion Criteria:
Established Type 1 and 2 Diabetes Mellitus diagnosis;
Pregnancy - Self-reported as currently pregnant, planning to become pregnant, or notpracticing contraception, in the following 10 months (if applicable);
Conditions precluding technology use (e.g. cognitive decline, dependent upon a carerfor daily activities);
Use of anti-obesity or diabetes medication, such as Metformin, Glucagon-likepeptide-1 analogue (GLP-1), or other medications known to significantly impactweight (either gain or loss), currently or within the preceding 3 months;
Following a prescribed medical diet;
Having undergone bariatric surgery within the past 3 years or planning surgerywithin the next 10 months;
Any mental health condition, including, but not limited to, eating disorders oralcohol/substance abuse, that would impact fully participating on the study;
Participating in a concurrent weight management program and/or relevantinterventional research protocol;
Contraindication to physical activity or weight loss;
Existing thyroid disorder;
Active cancer or less than 6 months from treatment;
Unable to provide informed consent or absence of a legal representative that canprovided it on behalf of the patient;
Institutionalised adults;
Foreseeable difficulty in attending study visits.
Study Design
Study Description
Connect with a study center
USF Cova da Piedade
Almada 2271961, Almada 2809-010
PortugalSite Not Available
USF Rosinha
Seixal 2263115, Amora 2845-422
PortugalSite Not Available
USF Charneca do Sol
Almada 2271961, Charneca Da Caparica 2820-225
PortugalSite Not Available
USF Inovar
Almada 2271961, Corroios 2855-697
PortugalSite Not Available
USF Saúde Laranjeiro
Almada 2271961, Fernão Ferro 2810-186
PortugalSite Not Available
USF Vista Tejo
Almada 2271961, Monte Da Caparica 2825-023
PortugalSite Not Available
Farmácia Alvide
Alcabideche,
PortugalSite Not Available
Farmácia Alvide
Alcabideche 2272215,
PortugalSite Not Available
Farmácia Largo do Coreto
Almada,
PortugalSite Not Available
Farmácia Nuno Álvares
Almada,
PortugalActive - Recruiting
Farmácia da Ramalha
Almada,
PortugalActive - Recruiting
USF São João do Pragal
Almada,
PortugalActive - Recruiting
Farmácia Largo do Coreto
Almada 2271961,
PortugalSite Not Available
Farmácia Nuno Álvares
Almada 2271961,
PortugalSite Not Available
Farmácia da Ramalha
Almada 2271961,
PortugalSite Not Available
USF São João do Pragal
Almada 2271961,
PortugalSite Not Available
Farmácia Romeiro
Amadora,
PortugalSite Not Available
Farmácia Romeiro
Amadora 2271772,
PortugalSite Not Available
Farmácia Santa Marta
Barreiro,
PortugalSite Not Available
Farmácia Santa Marta
Barreiro 2271071,
PortugalSite Not Available
Farmácia Vale Fetal
Caparica,
PortugalSite Not Available
Farmácia Vale Fetal
Caparica 2270229,
PortugalSite Not Available
USF Costa do Mar
Costa da Caparica,
PortugalSite Not Available
USF Costa do Mar
Costa da Caparica 7116497,
PortugalSite Not Available
Farmácia Quinta da Luz
Lisboa,
PortugalSite Not Available
Farmácia Quinta da Luz
Lisbon 2267057,
PortugalSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.